Could fewer shots prevent rabies? new trial tests simpler vaccine schedules
NCT ID NCT07275645
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial is testing whether simpler vaccination schedules for rabies are as effective as the standard 5-dose regimen. About 3,000 healthy people aged 10 to 60 will receive the vaccine in different patterns, including fewer total doses. Researchers will measure immune responses and track side effects to find the best balance of protection and convenience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rabies vaccine (human diploid cell), freeze-dried
- What this could lead to
- If successful, this could lead to simpler, fewer-dose vaccination schedules for rabies, making prevention easier and more accessible.
- What could go wrong
- This is a phase 3 trial, but it compares different schedules of an already approved vaccine type. The main risk is that simplified schedules may not be as effective as the standard one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gucheng county Center for Disease control and Prevention
Xiangyang, Hubei, China
-
Qichun County Center for Disease Control and Prevention
Huanggang, Hubei, China
-
Xiangzhou District Center for Disease Control and Prevention
Xiangyang, Hubei, China
-
Yunyang District Center for Disease Control and Prevention
Shiyan, Hubei, China
-
Zhushan county Center for Disease control and Prevention
Shiyan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental antibody cocktail offers hope for rabies patients with no other options
- New antibody cocktail aims to stop rabies after multiple dog bites
- New vaccines for yellow fever and rabies enter first human tests
- New rabies vaccine shows promise in large trial
- Could a tiny skin shot replace the big rabies needle?
- New rabies shot shows promise in preventing deadly infection after bites